Publicaciones en las que colabora con Pablo Juan Álvarez Aránega (30)

2017

  1. Gastrointestinal stromal tumours: An actualized overview

    European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112

2012

  1. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107

  2. Development and morphogenesis of human wrist joint during embryonic and early fetal period

    Journal of Anatomy, Vol. 220, Núm. 6, pp. 580-590

  3. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells

    Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567

  4. How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment

    Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888

  5. Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure

    International Journal of Molecular Sciences, Vol. 13, Núm. 12, pp. 16624-16635

  6. New gene therapy strategies for cancer treatment: A review of recent patents

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Núm. 3, pp. 297-312

  7. Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration

    Stem Cells and Development, Vol. 21, Núm. 4, pp. 562-574

  8. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

    Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 (Springer Netherlands), pp. 157-171

  9. The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis

    European Journal of Medicinal Chemistry, Vol. 50, pp. 376-382